CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Davidow Robert L 10% owner | Sale | −20,000 | $0.14 | $3K | 80,000 |
| 2023-09-08 | ROSENWALD LINDSAY A MD Director | Purchase | +348,675 | $0.72 | $251K | 354,318 |
| 2023-09-08 | Fortress Biotech, Inc. 10% owner | Purchase | +418,410 | $0.72 | $301K | 1,032,390 |
| 2023-06-30 | Charles Faith L. Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-30 | Jin David Interim PFO and COO | Grant or award · Employee stock option (right to buy) | +250,000 | 250,000 | ||
| 2023-06-30 | ROSENWALD LINDSAY A MD Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-30 | KRANZLER JAY D Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-30 | Oltmans Curtis Gale Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-30 | Herskowitz Neil Director | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-29 | MacLean Alexandra Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +800,000 | 800,000 | ||
| 2023-03-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +52,419 | 613,980 | ||
| 2023-01-03 | Fortress Biotech, Inc. 10% owner | Grant or award | +231,316 | 561,561 | ||
| 2022-12-31 | Fortress Biotech, Inc. 10% owner | Grant or award | +90,909 | 330,245 | ||
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. 10% owner | Sale | −388,888 | $7.71 | $3.0M | 0 |
| 2021-12-17 | KRANZLER JAY D Director | Grant or award | +49,020 | 113,683 | ||
| 2021-12-17 | KRANZLER JAY D Director | Grant or award | +20,000 | 133,683 | ||
| 2021-12-17 | Herskowitz Neil Director | Grant or award | +49,020 | 163,744 | ||
| 2021-12-17 | Herskowitz Neil Director | Grant or award | +20,000 | 183,744 | ||
| 2021-12-17 | Oltmans Curtis Gale Director | Grant or award | +49,020 | 49,020 | ||
| 2021-12-17 | Lu Lucy President, CEO | Grant or award | +411,616 | 748,949 |
Page 2 of 6 · 101 trades